2025 HCPCS code Q2039
(Active (Historically used as a temporary code)) Effective Date: N/A Revision Date: N/A Deletion Date: Jan 1, 2018 Immunizations - Split Virus Vaccines Influenza Virus Vaccines Feed
HCPCS code Q2039 represents an influenza virus vaccine (split virus), not otherwise specified, for intramuscular administration to individuals 3 years and older.
Modifiers may apply depending on the circumstances of the service, including place of service, the type of provider, and whether the service is part of a global package. Always consult current modifier guidelines.
Medical necessity is established based on CDC and ACIP guidelines recommending annual influenza vaccination for individuals aged 6 months and older.Specific risk factors such as age, underlying medical conditions, and pregnancy may increase the recommendation's strength.
The clinical responsibility lies with the healthcare professional administering the vaccine. This includes appropriate patient selection, administering the vaccine correctly, and documenting the procedure completely.
- Influenza Virus Vaccines
- HCPCS Level II, Category Q (Drugs, biologicals, and other medical equipment or services)
In simple words: This code is for a specific type of flu shot (a split-virus vaccine) given as a shot in the muscle.It's used for people age 3 and older when a more specific flu shot code isn't available.
HCPCS code Q2039, effective August 1, 2017, designates an influenza virus vaccine (split virus) that is not otherwise specified by another HCPCS code.This code is specifically for intramuscular administration in individuals aged 3 years and older.It was used as a temporary code until CPT code 90756 was implemented on January 1, 2018.Complete documentation should include the National Drug Code (NDC) number, vaccine name, dosage, strength, doses per vial (if applicable), and the amount of drug per unit.
Example 1: A 65-year-old patient receives a split-virus flu vaccine in a physician's office. Q2039 is used because the specific manufacturer's vaccine is not specified by a different HCPCS code., A 4-year-old child receives an intramuscular flu shot at a health clinic.The specific brand is unknown, so Q2039 is used., A patient at a Federally Qualified Health Center (FQHC) receives an influenza vaccination. The administration is documented, and the specific brand of split virus influenza vaccine is identified using the NDC number.
Complete documentation must include: patient demographics, date of service, vaccine administered (including NDC number, manufacturer, and lot number), dosage, route of administration (intramuscular), site of administration, any adverse reactions, and provider signature.
** This code was a temporary measure.Always ensure that you are using the most current and accurate codes for influenza vaccines. Refer to the most current CMS guidelines and coding manuals.
- Revenue Code: Revenue codes will vary depending on the payer and the specific circumstances of the service provided.
- RVU: RVUs are not directly assigned to HCPCS codes. Reimbursement is determined by the payer based on various factors including the place of service and other modifiers.
- Global Days : Not applicable; this is a vaccine administration code, not a surgical procedure.
- Payment Status: Active (Historically, payment was determined by the local claims processing contractor between 8/1/2017 and 7/31/2018)
- Modifier TC rule: Not applicable; this is a supply code, not a procedure with a technical component.
- Fee Schedule : Prior to January 1, 2018, payment was determined by local MACs.After this date, CPT 90756 should be used for reimbursement.
- Specialties:Family Medicine, Internal Medicine, Pediatrics, Occupational Medicine
- Place of Service:Office, Clinic, Health Center, Hospital Outpatient, Other